Gufic Biosciences Holds 42nd AGM on Sept 4, 2026, Discusses Financials and Dividend
Gufic Biosciences held its 42nd AGM on September 4, 2026, to adopt FY26 financial statements and approve a 10% final dividend. Key agenda items included director re-appointments and auditor remuneration ratification. Voting results will be published within two working days.
The announcement pertains to the procedural aspects of an Annual General Meeting, including the adoption of financial statements and dividend declaration. These are standard annual events and do not introduce new information that would materially impact the company's stock or operations.
The announcement reports on the proceedings of an Annual General Meeting, which is a routine corporate event. While it covers financial statement adoption and dividend declaration, it does not contain new financial performance data or significant strategic shifts that would warrant a positive or negative sentiment.
Gufic Biosciences Limited convened its 42nd Annual General Meeting (AGM) on Friday, September 04, 2026, conducted virtually via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The meeting commenced at 3:30 p.m. IST and concluded at 4:09 p.m. IST.
Chaired by Mr. Jayesh P. Choksi, Chairman & Managing Director, the AGM saw the presence of all directors and committee chairpersons, along with representatives from the statutory auditors and secretarial auditors. A total of 43 shareholders, including promoters and public investors, were present.
The agenda included the consideration and adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, along with the Board and Auditors' reports. Shareholders also voted on the declaration of a Final Dividend of 10%, amounting to Re. 0.10 per equity share of Re. 1/- face value. Other key agenda items involved the re-appointment of Mr. Pranav J. Choksi as a director retiring by rotation, the ratification of remuneration for Cost Auditors M/s. Poddar & Co. for FY 2026-27, and the re-appointment of Mr. Pankaj J Gandhi as Whole Time Director.
Remote e-voting facilities were provided through NSDL prior to the AGM, and e-voting was also available during the meeting. The consolidated scrutinizer's report on the voting results will be made available on the websites of the stock exchanges and the company within two working days of the meeting's conclusion.
A plain-language summary of a public exchange filing by Gufic Biosciences Limited. Read the original for the full detail.
